NCT07217990Not yet recruitingPhase 1/2
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
Source: ClinicalTrials.gov · Last updated 24 Jun 2026
Brief summary (registry, in English)
This study will evaluate the efficacy and non-inferiority of a non-surgical approach for the treatment of patients with locally advanced breast cancer.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- First submitted
- 15 Oct 2025
- Start date
- Sept 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Ohio State University Comprehensive Cancer Center
- Diseases
- Triple-negative breast cancer
- NCT number
- NCT07217990
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 84
- From Sept 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with an investigational drug or other intervention throughout their breast cancer treatment
Other
- Pregnancy or lactation
- Inmate or prisoner
- Patients with skin involvement and/or distant metastases
Who the study is looking for
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged 18 years or older
- Early-stage breast cancer diagnosis (cT1-3 N0 or cT1-2 N1) and a Human Epidermal Receptor 2 (HER2)-positive or triple negative breast cancer (TNBC) tumor molecular subtype
- Planning to receive neoadjuvant chemotherapy (NAC) and radiation therapy (RT)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ohio State University Comprehensive Cancer Center Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.